These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1980362)

  • 41. [Current developments in the pharmacology of dopaminergic receptors (I)].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current developments in the pharmacology of dopaminergic receptors (II)].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123
    [No Abstract]   [Full Text] [Related]  

  • 43. [Current developments in the pharmacology of the dopaminergic receptors. III].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
    [No Abstract]   [Full Text] [Related]  

  • 44. Regression estimation from grouped observations applied to structurally diverse D2-receptor antagonists.
    Mager PP; Rothe H
    Pharmazie; 1990 Jun; 45(6):424-33. PubMed ID: 1976263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical use of dopamine receptor agonists.
    Murphy MB
    Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral dopaminergic nerves.
    Bell C
    Pharmacol Ther; 1989; 44(2):157-79. PubMed ID: 2577510
    [No Abstract]   [Full Text] [Related]  

  • 48. Dopamine: receptors and clinical applications.
    Goldberg LI
    Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presynaptic receptors for dopamine, histamine, and serotonin.
    Feuerstein TJ
    Handb Exp Pharmacol; 2008; (184):289-338. PubMed ID: 18064418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.
    Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ
    Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954
    [No Abstract]   [Full Text] [Related]  

  • 53. Therapeutic applications of drugs acting on peripheral dopamine receptors.
    Horn PT; Murphy MB
    J Clin Pharmacol; 1990 Aug; 30(8):674-9. PubMed ID: 1976128
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.
    Waddington JL
    Gen Pharmacol; 1988; 19(1):55-60. PubMed ID: 3278946
    [No Abstract]   [Full Text] [Related]  

  • 55. Dopamine receptor agonists and antagonists.
    Kohli JD
    Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.